問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD933IC00003
Completed

2018-02-05 - 2022-12-31

Phase II

Terminated9

ICD-10C67

Malignant neoplasm of bladder

ICD-9233.9

Carcinoma in situ of other and unspecified urinary organs

  • Trial Applicant

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Jian-Ri Li Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Wen-Pin Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Principal Investigator Yu-Li Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Su-Peng Yeh Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Yu-Chieh Tsai Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Principal Investigator Wen-Jeng Wu Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Yen-Hwa Chang Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 蘇穎文 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator

Co-Principal Investigator

Audit

None

Principal Investigator See-Tong Pang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

3 Stop recruiting

Audit

None

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    125 participants

  • Global

    375 participants